Nov 28, 2025 · Entyvio is used to treat moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) in adults. Entyvio infusion is administered intravenously for the first two doses, followed …

Jul 31, 2024 · Find patient medical information for Entyvio (vedolizumab) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Nov 21, 2025 · Learn about the side effects, dosage, and more of Entyvio (vedolizumab) infusions and injections. It's a prescription drug that treats inflammatory bowel disease (IBD).

If you are taking a biologic therapy, such as infliximab (Remicade®), adalimumab (Humira®), vedolizumab (Entyvio®), or ustekinumab (Stelara®), to treat inflammatory bowel disease (IBD), you …

Nov 23, 2025 · Are Entyvio and vedolizumab the same? Yes, Entyvio is the brand name for the active drug vedolizumab. Learn more about this biologic treatment for IBD.

Jun 3, 2025 · Learn about Entyvio (vedolizumab) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.

Apr 16, 2025 · Vedolizumab is the generic name for Entyvio, a biologic therapy used to treat moderate to severe Crohn’s disease and ulcerative colitis.

Vedolizumab is a prescription medication used for the treatment of ulcerative colitis and Crohn's disease. Learn about this generic drug, uses, side effects, dosages, drug interactions, and warnings.

Feb 23, 2024 · Generic name: vedolizumab Brand name: Entyvio Dosage form: intravenous infusion (300 mg single-dose vial), subcutaneous injection (108 mg/0.68 mL prefilled syringe), (108 mg/0.68 …

Entyvio, also known by its generic name Vedolizumab, is a medical drug used to treat moderate to severe ulcerative colitis and Crohn’s disease in patients who don’t show improvement while on other …